StableX (SBLX) director gets 22,723 options at $6.25
StableX Technologies, Inc. (SBLX) director Wayne Walker reported an option grant.
Rhea-AI Filing Summary
StableX Technologies, Inc. (SBLX) director Wayne Walker reported an option grant. On 10/31/2025, he received 22,723 employee stock options with a $6.25 exercise price.
The grant vests 75% at the date of grant and 25% on December 31, 2025, provided he continues to provide services to the company on that date. Following the transaction, 22,723 derivative securities were beneficially owned on a direct basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,723 shares
Grant/Award
1 txn
Insider
WALKER WAYNE REMELL
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy | 22,723 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy — 22,723 contracts (Direct)
Footnotes (1)
- F1. The stock options vest as follows: (i) 75% vested upon the date of grant; and (ii) 25% will vest on December 31, 2025, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date.
FAQ
What did StableX (SBLX) disclose in this Form 4?
A director, Wayne Walker, received 22,723 employee stock options at a $6.25 exercise price on 10/31/2025.
What is the vesting schedule for the SBLX options grant?
75% vested upon grant; 25% will vest on December 31, 2025, contingent on continued service.
How many derivative securities are owned after the transaction?
22,723 derivative securities were beneficially owned following the transaction.
What is the ownership form of the reported securities?
The ownership form is Direct (D).
What role does the reporting person have at StableX (SBLX)?
The reporting person is a Director.
What is the exercise price of the reported options?
The exercise price is $6.25 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.